Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Bernhard Rauch
The EACPR Cardiac Rehabilitation Section comments on:
Comment: From the prospective Acute COronary Syndromes (ACOS) registry 4,547 consecutive patients after ST-elevation- (STEMI: n = 2,432) or non-ST-elevation myocardial infarction (NSTEMI: n = 2,115), recruited between June 2000 and December 2002, were evaluated for clinical outcomes during 1-year follow-up 1. Cardiac rehabilitation (CR) participation rate was 67.8% (STEMI) and 52.3% (NSTEMI) respectively. Multivariable analysis adjusting for propensity score shows that CR was independently associated with a significant reduction of all-cause mortality (STEMI: OR 0.41, 95% CI 0.28-0.60; NSTEMI: OR 0.53, 95% CI 0.38-0.76) and Major Adverse Cardiac and Cerebrovascular Events (STEMI: OR 0.66, 95% CI 0.49-0.89; NSTEMI: OR 073, 95% CI 0.55-0.98). Particularly patients with elevated risk (age above 70 years, diabetes mellitus, left ventricular ejection fraction < 40%) derived advantage from rehabilitation as expressed by the number needed to be exposed. The major limitation of the study is not to be a prospective randomized trial. Unequal distribution of risk factors relevant for long-term prognosis had to be corrected by multivariable analysis adjusting for propensity score. Despite prospective randomized trials on clinical and social long-term effects of various rehabilitation programs are urgently needed, such studies are not funded in Germany at present. The recently published GOSPEL study, however, may serve as an example that national prospective multicenter trials evaluating CR are feasible. It therefore is time to think about a multinational trial evaluating the effect of cardiac rehabilitation on prognostic, social and economic measures.